Prot# CA180267: An Open-Label Trial to Evaluate the Safety of Dasatinib in the Treatment of Scleroderma Pulmonary Interstitial Fibrosis

Project: Research project

Project Details

Status	Finished
Effective start/end date	1/22/09 → 1/22/12